Skip to main content
. 2017 Sep 24;18(10):2049. doi: 10.3390/ijms18102049
FD Fabry disease
Gb3 Globotriaosylceramide
ERT Enzymatic replacement therapy
DGJ 1-Deoxygalactonojirimycin